Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

Cited by (1,000)

Items 101–200 of 1,000

1. Drug discovery in dementia: the role of rodent models
   Debby Van Dam, Peter Paul De Deyn · 2006 · Nature Reviews Drug Discovery
2. Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice
   Janelsins, Michelle C., Mastrangelo, Michael A., Park, Keigan M., Sudol, Kelly L., Narrow, Wade C., Oddo, Salvatore, LaFerla, Frank M., Callahan, Linda M., Federoff, Howard J., Bowers, William J. · 2008 · The American Journal of Pathology
3. Neuronal Apoptosis in Neurodegeneration
   Masahiro Okouchi, Oleksandr Y. Ekshyyan, Magdalena Maracine, Tak Yee Aw · 2007 · Antioxidants and Redox Signaling
4. Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
   Saeid Safiri, Amir Ghaffari Jolfayi, Asra Fazlollahi, Soroush Morsali, Aila Sarkesh, Amin Daei Sorkhabi, Behnam Golabi, Reza Aletaha, Kimia Motlagh Asghari, Sana Hamidi et al. · 2024 · Frontiers in Medicine
5. Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
   Hilda Martínez‐Coria, Kim N. Green, Lauren M. Billings, Masashi Kitazawa, Miriam Albrecht, Gerhard Rammes, Chris G. Parsons, Sandeep Gupta, Pradeep Banerjee, Frank M. LaFerla · 2009 · American Journal Of Pathology
6. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease
   Blanca Ramos, David Baglietto‐Vargas, Juan Carlos del Río, Inés Moreno‐González, Consuelo Santa‐María, Sebastián Jiménez, Cristina Caballero, Juan Felix Lopez-Tellez, Zafar U. Khan, Diego Ruano et al. · 2005 · Neurobiology of Aging
7. Early Astrocytic Atrophy in the Entorhinal Cortex of a Triple Transgenic Animal Model of Alzheimer’s Disease
   Chia‐Yu Yeh, Bhamini Vadhwana, Alexei Verkhratsky, Jose Julio Rodriguez · 2011 · ASN NEURO
8. Brain Imaging of Nicotinic Receptors in Alzheimer's Disease
   Jin Wu, Masatomo Ishikawa, Jichun Zhang, Kenji Hashimoto · 2010 · International Journal of Alzheimer s Disease
9. CC Chemokine Receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease
   Naert, Gaëlle, Rivest, Serge · 2011 · The Journal of Neuroscience
10. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease
    Kurt R. Stover, Mackenzie A. Campbell, Christine M. Van Winssen, Richard E. Brown · 2015 · Behavioural Brain Research
11. Updates in Alzheimer's disease: from basic research to diagnosis and therapies
    Enjie Liu, Yao Zhang, Jian–Zhi Wang · 2024 · Translational Neurodegeneration
12. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
    Yan‐Jiang Wang, Huadong Zhou, Xin‐Fu Zhou · 2006 · Drug Discovery Today
13. Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
    David Tweedie, Ryan A. Ferguson, Kelly Fishman, Kathryn A. Frankola, Henriette van Praag, Harold W. Holloway, Weiming Luo, Yazhou Li, Luca Caracciolo, Isabella Russo et al. · 2012 · Journal of Neuroinflammation
14. The β-Secretase-Derived C-Terminal Fragment of βAPP, C99, But Not Aβ, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus
    Lauritzen, Inger, Pardossi-Piquard, Raphaëlle, Bauer, Charlotte, Brigham, Elizabeth, Abraham, Jean-Daniel, Ranaldi, Sébastien, Fraser, Paul, St-George-Hyslop, Peter, Le Thuc, Ophelia, Espin, Vanessa et al. · 2012 · The Journal of Neuroscience
15. Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease
    Gustavo Dziewczapolski, Michał Głogowski, E. Masliah, Stephen F. Heinemann · 2009 · Journal of Neuroscience
16. p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid βIn Vivo
    Jonathan C. Cruz, Dohoon Kim, Lily Y. Moy, Matthew M. Dobbin, Xiaoyan Sun, Roderick Terry Bronson, Li‐Huei Tsai · 2006 · Journal of Neuroscience
17. Tumor necrosis factor α Inhibition for Alzheimer’s Disease
    Chang, Rudy, Yee, Kei-Lwun, Sumbria, Rachita K · 2017 · Journal of Central Nervous System Disease
18. Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
    David X. Medina, Antonella Caccamo, Salvatore Oddo · 2010 · Brain Pathology
19. Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
    Ann Carolyn McKee, Isabel Carreras, Lokman Hossain, Hoon Ryu, William L. Klein, Salvatore Oddo, Frank M. LaFerla, Bruce G. Jenkins, Neil W. Kowall, Alpaslan Dedeoglu · 2008 · Brain Research
20. Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients
    Rebekah Patton, Walter M. Kalback, Chera L. Esh, Tyler A. Kokjohn, Gregory D. Van Vickle, Dean C. Luehrs, Yu‐Min Kuo, John C. Lopez, Daniel C. Brune, Isidró Ferrer et al. · 2006 · American Journal Of Pathology
21. Brain Bioavailability of Human Intravenous Immunoglobulin and its Transport through the Murine Blood–Brain Barrier
    Isabelle St‐Amour, Isabelle Paré, Waël Alata, Katherine Coulombe, Cassandra Ringuette Goulet, Janelle Drouin‐Ouellet, Milène Vandal, Denis Soulet, Renée Bazin, Frédéric Calon · 2013 · Journal of Cerebral Blood Flow & Metabolism
22. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
    Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bézard, Benjamin Dehay, Anthony Tsarbopoulos · 2015 · Progress in Neurobiology
23. Updates on mouse models of Alzheimer’s disease
    Zhong, Michael Z., Peng, Thomas, Duarte, Mariana Lemos, Wang, Minghui, Cai, Dongming · 2024 · Molecular Neurodegeneration
24. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction
    Carlo Corona, Francesca Masciopinto, Elena Silvestri, Adelaide Del Viscovo, Rossano Lattanzio, Rossana La Sorda, Domenico Ciavardelli, Fernando Goglia, Mauro Piantelli, Lorella M.T. Canzoniero et al. · 2010 · Cell Death and Disease
25. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
    Yang Liu, Sai An, Jianfeng Li, Yuyang Kuang, Xi He, Yubo Guo, Haojun Ma, Yu Zhang, Bin Ji, Chen Jiang · 2015 · Biomaterials
26. Intraneuronal β-Amyloid Accumulation in the Amygdala Enhances Fear and Anxiety in Alzheimer's Disease Transgenic Mice
    Judit España, Lydia Giménez‐Llort, Jorge Valero, Alfredo Jesús Miñano-Molina, Alberto Rábano, José Rodrı́guez-Álvarez, Frank M. LaFerla, Carlos A. Saura · 2009 · Biological Psychiatry
27. Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice
    Carlo Corona, Valério Frazzini, Elena Silvestri, Rossano Lattanzio, Rossana La Sorda, Mauro Piantelli, Lorella M.T. Canzoniero, Domenico Ciavardelli, Enrico Rizzarelli, Stefano Luca Sensi · 2011 · PLoS ONE
28. Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model
    Yongfang Zhang, Pradeep K. Kurup, Jian Xu, Nikisha Carty, Stephanie M. Fernandez, Haakon B. Nygaard, Christopher Pittenger, Paul Greengard, Stephen M. Strittmatter, Angus Clark Nairn et al. · 2010 · Proceedings of the National Academy of Sciences
29. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity
    Massimo Stefani · 2010 · FEBS Journal
30. Effects of in vivo conditions on amyloid aggregation
    Michael C. Owen, David Gnutt, Mimi Gao, Sebastian K.T.S. Wärmländer, Jüri Jarvet, Astrid Gräslund, Roland Winter, Simon Ebbinghaus, Birgit Strodel · 2019 · Chemical Society Reviews
31. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated A in AD models
    Preeti J. Khandelwal, Alexander M. Herman, Hyang‐Sook Hoe, George William Rebeck, C. E.- H. Moussa · 2011 · Human Molecular Genetics
32. Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory
    Jorge Valero, Giorgia Mastrella, Ismael Neiva, Silvia Sánchez, João Oliveira Malva · 2014 · Frontiers in Neuroscience
33. Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.
    Kitazawa, Masashi, Medeiros, Rodrigo, M. LaFerla, Frank · 2012 · Current Pharmaceutical Design
34. β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution
    Zhenglin Gu, Wenhua Liu, Zhen Yan · 2009 · Journal of Biological Chemistry
35. Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits
    Massimo Stefani · 2012 · Progress in Neurobiology
36. Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity
    Terence Y. Pang, Anthony John Hannan · 2012 · Neuropharmacology
37. Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
    Wirths, Oliver, Breyhan, Henning, Cynis, Holger, Schilling, Stephan, Demuth, Hans-Ulrich, Bayer, Thomas A. · 2009 · Acta Neuropathologica
38. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice
    NELSON, R, GUO, Z, HALAGAPPA, V, PEARSON, M, GRAY, A, MATSUOKA, Y, BROWN, M, MARTIN, B, IYUN, T, MAUDSLEY, S · 2007 · Experimental Neurology
39. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease
    Min Huang, Xin Jiang, Yubin Liang, Qiong Liu, Siyan Chen, Yi Chen Guo · 2017 · Experimental Gerontology
40. Interactions between APP secretases and inflammatory mediators
    Magdalena Sastre, Jochen Walter, Steve Gentleman · 2008 · Journal of Neuroinflammation
41. Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic Receptors
    Esperanza Arias, Sonia Gallego‐Sandín, Mércedes Villarroya, Antonio G. Garcı́a, Manuela G. López · 2005 · Journal of Pharmacology and Experimental Therapeutics
42. Targeting mitophagy in neurodegenerative diseases
    Odetta Antico, Paul W. Thompson, Nicholas T. Hertz, Miratul M. K. Muqit, Laura E. Parton · 2025 · Nature Reviews Drug Discovery
43. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model
    Romain Roger Fol, Jérôme Braudeau, Susann Ludewig, Tobias Abel, Sascha W. Weyer, Jan-Peter Roederer, Florian Brod, Mickaël Audrain, Alexis‐Pierre Bemelmans, Christian J. Buchholz et al. · 2015 · Acta Neuropathologica
44. Human neural stem cells alleviate Alzheimer-like pathology in a mouse model
    Il-Shin Lee, Kwangsoo Jung, Il‐Sun Kim, Hae-Jin Lee, Miri Kim, Seokhwan Yun, Kyujin Hwang, Jeong Eun Shin, Kook In Park · 2015 · Molecular Neurodegeneration
45. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model
    Alfonso Grimaldi, Carlo Brighi, Giovanna Peruzzi, Davide Ragozzino, Valentina Bonanni, Cristina Limatola, Giancarlo Ruocco, Silvia Di Angelantonio · 2018 · Cell Death and Disease
46. A Shortened Barnes Maze Protocol Reveals Memory Deficits at 4-Months of Age in the Triple-Transgenic Mouse Model of Alzheimer's Disease
    Aida Attar, Tingyu Liu, Wai-Ting Coco Chan, Jane Hayes, Mona Nejad, KaiChyuan Lei, Gal Bitan · 2013 · PLoS ONE
47. Adult hippocampal neurogenesis in Alzheimer’s disease: A roadmap to clinical relevance
    Evgenia Salta, Orly Lazarov, Carlos Patricio Fitzsimons, Rudolph E. Tanzi, Paul John Lucassen, Se Hoon Choi · 2023 · Cell stem cell
48. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
    Youmans, Katherine L, Tai, Leon M, Kanekiyo, Takahisa, Stine Jr, W Blaine, Michon, Sara-Claude, Nwabuisi-Heath, Evelyn, Manelli, Arlene M, Fu, Yifan, Riordan, Sean, Eimer, William A et al. · 2012 · Molecular Neurodegeneration
49. Increased intraneuronal resting [Ca²⁺] in adult Alzheimer’s disease mice
    Lopez, José R., Lyckman, Alvin, Oddo, Salvatore, LaFerla, Frank M., Querfurth, Henry W., Shtifman, Alexander · 2008 · Journal of Neurochemistry
50. A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models
    Ju‐Xian Song, Sandeep Malampati, Yu Xiao Zeng, Siva Sundara Kumar Durairajan, Chuanbin Yang, Benjamin Chun‐Kit Tong, Ashok Iyaswamy, Wenbin Shang, Sravan Gopalkrishnashetty Sreenivasmurthy, Zhou Zhu et al. · 2019 · Aging Cell
51. Effects of Synaptic Modulation on β-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice
    Davide Tampellini, Estibaliz Capetillo‐Zarate, Magali Dumont, Zhenyong Huang, Fangmin Yu, Michael T. S. Lin, Gunnar K. Gouras · 2010 · Journal of Neuroscience
52. Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?
    Aleksandar Peric, Wim G. Annaert · 2015 · Acta Neuropathologica
53. Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer's Disease
    Magali Dumont, Khatuna Kipiani, Fangmin Yu, Elizabeth J. Wille, Maya Katz, Noel Ylagan Calingasan, Gunnar K. Gouras, Michael T. S. Lin, M. Flint Beal · 2011 · Journal of Alzheimer s Disease
54. Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept)
    Carola Romberg, Mark P. Mattson, Mohamed R. Mughal, Timothy J. Bussey, Lisa M. Saksida · 2011 · Journal of Neuroscience
55. Chronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
    Satomi Shiota, Hidenori Takekawa, Shin‐ei Matsumoto, Kazuya Takeda, Fariz Nurwidya, Yasuko Yoshioka, Fumiyuki Takahashi, Nobutaka Hattori, Takeshi Tabira, Hideki Mochizuki et al. · 2013 · Journal of Alzheimer s Disease
56. Interactions of Pathological Hallmark Proteins
    Judit Oláh, Orsolya Vincze, Dezső Péter Virok, Dóra Simon, Zsolt Bozsó, Natália Tőkési, István Horváth, Emma Hlavanda, János Kovács, Anna Magyar et al. · 2011 · Journal of Biological Chemistry
57. Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders
    Susan M.G. Goody, Matthew L. Baum, Constantinos D. Paspalas, Stephanie M. Fernandez, Nikisha Carty, Pradeep K. Kurup, Paul J. Lombroso · 2011 · Pharmacological Reviews
58. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease
    Marius Chiasseu, Luis Alarcón-Martínez, Nicolás Belforte, Heberto Quintero, Florence Dotigny, Laurie Destroismaisons, Christine Vande Velde, Fany Panayi, Caroline Louis, Adriana Di Polo · 2017 · Molecular Neurodegeneration
59. Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
    Castillo, Erika, Leon, Julio, Mazzei, Guianfranco, Abolhassani, Nona, Haruyama, Naoki, Saito, Takashi, Saido, Takaomi, Hokama, Masaaki, Iwaki, Toru, Ohara, Tomoyuki et al. · 2017 · Scientific Reports
60. An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
    Anna Lord, Astrid Gumucio, Hillevi Englund, Dag Sehlin, Valentina Screpanti Sundquist, Linda Söderberg, Christer Möller, Pär Gellerfors, Lars Lannfelt, Frida Ekholm Pettersson et al. · 2009 · Neurobiology of Disease
61. Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
    Anne Eckert, Kathrin L. Schulz, Virginie F. Rhein, Jürgen Götz · 2010 · Molecular Neurobiology
62. Apomorphine treatment in Alzheimer mice promoting amyloid‐β degradation
    Eri Himeno, Yasumasa Ohyagi, Linqing Ma, Norimichi Nakamura, Katsue Miyoshi, Nobutaka Sakae, Kyoko Motomura, Naoko Soejima, Ryo Yamasaki, Tetsuya Hashimoto et al. · 2010 · Annals of Neurology
63. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
    Anekonda, Thimmappa S., Quinn, Joseph F., Harris, Christopher, Frahler, Kate, Wadsworth, Teri L., Woltjer, Randall L. · 2011 · Neurobiology of Disease
64. Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease
    Emily Rose Rosario, Jenna C. Carroll, Salvatore Oddo, Frank M. LaFerla, Christian J. Pike · 2006 · Journal of Neuroscience
65. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers
    Rakez Kayed, Isabel Canto, Leonid Breydo, Suhail Rasool, Tamás Lukácsovich, Jessica Wu, Ricardo Albay, Anna Pensalfini, Stephen T. Yeung, Elizabeth Head et al. · 2010 · Molecular Neurodegeneration
66. Interneuron Accumulation of Phosphorylated tau Impairs Adult Hippocampal Neurogenesis by Suppressing GABAergic Transmission.
    Jie Zheng, Hong-Lian Li, Na Tian, Fei Liu, Lu Wang, Ya-Ling Yin, Lu-Peng Yue, Longyu Ma, Y. Wan, Jian-Zhi Wang · 2020 · Cell Stem Cell
67. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease
    Joannee Zumkehr, Carlos J. Rodríguez‐Ortiz, David Cheng, Zanett Kieu, Thin Wai, Charlesice Hawkins, Jason Kilian, Sharon Lim, Rodrigo Medeiros, Masashi Kitazawa · 2015 · Neurobiology of Aging
68. Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
    Pavlos Alifragis, Jade Marsh · 2018 · Neural Regeneration Research
69. Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
    Takahashi, Reisuke H., Capetillo-Zarate, Estibaliz, Lin, Michael T., Milner, Teresa A., Gouras, Gunnar K. · 2010 · Neurobiology of Aging
70. Neuronal protection by sirtuins in Alzheimer's disease
    Thimmappa S. Anekonda, P. Hemachandra Reddy · 2005 · Journal of Neurochemistry
71. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer’s disease mice
    Bittner, Tobias, Fuhrmann, Martin, Burgold, Steffen, Ochs, Simon M., Hoffmann, Nadine, Mitteregger, Gerda, Kretzschmar, Hans, LaFerla, Frank M., Herms, Jochen · 2010 · PLoS ONE
72. Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
    Prashant R. Bharadwaj, Ashok Kumar Dubey, Colin Louis Masters, Ralph Nigel Martins, Ian George Macreadie · 2008 · Journal of Cellular and Molecular Medicine
73. Relevance of Transgenic Mouse Models to Human Alzheimer Disease
    Debbi Ann Morrissette, Anna I. Parachikova, Kim N. Green, Frank M. LaFerla · 2008 · Journal of Biological Chemistry
74. Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
    Eriksen, Jason L., Janus, Christopher G. · 2007 · Behavior Genetics
75. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease
    Kaige Ma, Yi‐Hua Qian · 2018 · Neuropeptides
76. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases
    Damien J. Keating · 2007 · Journal of Neurochemistry
77. Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1
    Bettina Platt, Benjamin D. Drever, David J. Koss, Sandra Stoppelkamp, Amar Jyoti, Andrea Plano, Anelì Utan, Georgina Merrick, Duncan Ryan, Valeria Melis et al. · 2011 · PLoS ONE
78. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models
    Zhan Zhang, Qi Shen, Xiaolei Wu, Di Zhang, Da Xing · 2019 · Aging Cell
79. HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons
    Roberto Piacentini, Livia Civitelli, Cristian Ripoli, Maria Elena Marcocci, Giovanna De Chiara, Enrico Garaci, Gian Battista Azzena, Anna Teresa Palamara, Claudio Grassi · 2010 · Neurobiology of Aging
80. Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice
    Lauren M. Billings, Kim N. Green, James Lafayette McGaugh, Frank M. LaFerla · 2007 · Journal of Neuroscience
81. Direct Observations of Amyloid β Self-Assembly in Live Cells Provide Insights into Differences in the Kinetics of Aβ(1–40) and Aβ(1–42) Aggregation
    Elin K. Esbjörner, Fiona Chan, Eric J. Rees, Miklós Erdélyi, Leila M. Luheshi, Carlos W. Bertoncini, Clemens F. Kaminski, Christopher Martin Dobson, Gabriele S. Kaminski Schierle · 2014 · Chemistry & Biology
82. Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
    Scott J. Webster, Adam D. Bachstetter, Linda J. Van Eldik · 2013 · Alzheimer s Research & Therapy
83. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)
    Mohammed Filali, Robert Lalonde, Peter Thériault, Carl Julien, Frédéric Calon, Emmanuel Planel · 2012 · Behavioural Brain Research
84. Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
    Suzhen Dong, Yale Duan, Yinghe Hu, Zheng Zhao · 2012 · Translational Neurodegeneration
85. Brain cholinergic vulnerability: Relevance to behavior and disease
    Michael McKinney · 2005 · Biochemical Pharmacology
86. Nobiletin, a Citrus Flavonoid, Improves Cognitive Impairment and Reduces Soluble Aβ Levels in a Triple Transgenic Mouse Model of Alzheimer’s Disease (3XTg-AD)
    Nakajima, Akira, Aoyama, Yuki, Shin, Eun-Joo, Nam, Yunsung, Kim, Hyoung-Chun, Nagai, Taku, Yokosuka, Akihito, Mimaki, Yoshihiro, Yokoi, Tsuyoshi, Ohizumi, Yasushi et al. · 2015 · Behavioural Brain Research
87. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition
    Frank Gillardon, Wolfgang Rist, Lothar Kußmaul, Johannes Vogel, Matthias Berg, Karin M. Danzer, Norbert Kraut, Bastian Hengerer · 2007 · PROTEOMICS
88. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
    Baruh Polis, Abraham O. Samson · 2020 · Neural Regeneration Research
89. Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
    Cristian A. Lasagna‐Reeves, Charles G. Glabe, Rakez Kayed · 2011 · Journal of Biological Chemistry
90. Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals
    Ian F. Smith, Kim N. Green, Frank M. LaFerla · 2005 · Cell Calcium
91. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
    Van der Jeugd, Ann, Hochgräfe, Katja, Ahmed, Tariq, Decker, Jochen M., Sydow, Astrid, Hofmann, Anne, Wu, Dan, Messing, Lars, Balschun, Detlef, D’Hooge, Rudi et al. · 2012 · Acta Neuropathologica
92. Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease
    Lloret, A., Fuchsberger, T., Giraldo, E., Viña, J. · 2015 · Free Radical Biology and Medicine
93. A polysaccharide from Polygonatum sibiricum attenuates amyloid-β-induced neurotoxicity in PC12 cells
    Huixue Zhang, Yuze Cao, Lixia Chen, Jianjian Wang, Qinghua Tian, Ning Wang, Zhaojun Liu, Jie Li, Na Wang, Xiaokun Wang et al. · 2014 · Carbohydrate Polymers
94. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy
    J. Shacka John · 2007 · Frontiers in bioscience
95. Cholesterol in Alzheimers Disease: Unresolved Questions
    Massimo Stefani, Gianfranco Liguri · 2009 · Current Alzheimer Research
96. LRP in Amyloid‐β Production and Metabolism
    Guojun Bu, Judy A. Cam, Celina Zerbinatti · 2006 · Annals of the New York Academy of Sciences
97. Spines, plasticity, and cognition in Alzheimer's model mice
    Spires-Jones, Tara, Knafo, Shira · 2012 · Neural Plasticity
98. β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
    Botond Penke, Ferenc Bogár, Lívia Fülöp · 2017 · Molecules
99. The role of nicotinic acetylcholine receptors in Alzheimer’s disease
    Salvatore Oddo, Frank M. LaFerla · 2006 · Journal of Physiology-Paris
100. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms
     Jonathan T. Ting, Brooke G. Kelley, Talley J. Lambert, David G. Cook, Jane Sullivan · 2006 · Proceedings of the National Academy of Sciences